X0609 4 2026-05-14 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001798443 Kalif Eliyahu Sharon true C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV ISRAEL L3 6944020 ISRAEL false true false false EVP, Chief Financial Officer true Ordinary Shares 2026-05-14 4 S false 153251 35.6107 D 172184 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.59 to $35.80, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Dov Bergwerk as attorney-in-fact for Eliyahu Sharon Kalif 2026-05-18